[go: up one dir, main page]

NO20001847L - Ny anvendelse av forbindelser for anti-kløe-aktivitet - Google Patents

Ny anvendelse av forbindelser for anti-kløe-aktivitet

Info

Publication number
NO20001847L
NO20001847L NO20001847A NO20001847A NO20001847L NO 20001847 L NO20001847 L NO 20001847L NO 20001847 A NO20001847 A NO 20001847A NO 20001847 A NO20001847 A NO 20001847A NO 20001847 L NO20001847 L NO 20001847L
Authority
NO
Norway
Prior art keywords
compounds
new use
itch activity
itch
activity
Prior art date
Application number
NO20001847A
Other languages
English (en)
Other versions
NO20001847D0 (no
Inventor
Don Edgar Griswold
Iv Siegfried Benja Christensen
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20001847D0 publication Critical patent/NO20001847D0/no
Publication of NO20001847L publication Critical patent/NO20001847L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20001847A 1997-10-17 2000-04-10 Ny anvendelse av forbindelser for anti-kløe-aktivitet NO20001847L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6374697P 1997-10-17 1997-10-17
PCT/US1998/021886 WO1999020280A1 (en) 1997-10-17 1998-10-16 Novel use of compounds for anti-pruritic activity

Publications (2)

Publication Number Publication Date
NO20001847D0 NO20001847D0 (no) 2000-04-10
NO20001847L true NO20001847L (no) 2000-04-10

Family

ID=22051225

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001847A NO20001847L (no) 1997-10-17 2000-04-10 Ny anvendelse av forbindelser for anti-kløe-aktivitet

Country Status (18)

Country Link
EP (1) EP1030666A4 (no)
JP (1) JP2001520196A (no)
KR (1) KR20010031149A (no)
CN (1) CN1306426A (no)
AR (1) AR015966A1 (no)
AU (1) AU740875B2 (no)
BR (1) BR9814080A (no)
CA (1) CA2306985A1 (no)
CO (1) CO4810374A1 (no)
CZ (1) CZ20001376A3 (no)
HU (1) HUP0003792A3 (no)
IL (1) IL135581A0 (no)
NO (1) NO20001847L (no)
NZ (1) NZ503551A (no)
PL (1) PL341062A1 (no)
TR (1) TR200001040T2 (no)
WO (1) WO1999020280A1 (no)
ZA (1) ZA989450B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20031902A3 (cs) 2001-01-31 2004-07-14 Pfizer Products Inc. Etherové deriváty užitečné jako inhibitory isozymů PDE4
IL156412A0 (en) 2001-01-31 2004-01-04 Pfizer Prod Inc Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
OA12540A (en) 2001-01-31 2006-06-05 Pfizer Prod Inc Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes.
US7250518B2 (en) 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
US20030175314A1 (en) * 2001-11-19 2003-09-18 Didriksen Erik Johannes Pharmaceutical composition for dermal application
TW200503709A (en) * 2003-07-17 2005-02-01 Santen Pharmaceutical Co Ltd Itching treating agent containing piperidine derivative as active ingredient
JP2005187458A (ja) * 2003-12-04 2005-07-14 Santen Pharmaceut Co Ltd シロミラストまたはその塩を有効成分とする掻痒治療剤
WO2005053672A1 (ja) * 2003-12-04 2005-06-16 Santen Pharmaceutical Co., Ltd. シロミラストまたはその塩を有効成分とする掻痒治療剤
DK1781657T3 (da) * 2004-02-14 2013-06-10 Glaxosmithkline Ip Dev Ltd Medikamenter med hm74a-receptor aktivitet
JP2008137892A (ja) * 2005-03-04 2008-06-19 Eisai Co Ltd 止痒剤
SI1912991T1 (sl) 2005-08-10 2011-03-31 Glaxosmithkline Llc One Franklin Plaza Derivati ksantina kot selektivni hm74a agonisti
PL1992622T3 (pl) * 2006-02-21 2012-01-31 Eisai R&D Man Co Ltd Pochodna 4-(3-benzoiloaminofenylo)-6,7-dimetoksy-2-metyloaminochinazoliny
TWI404709B (zh) * 2006-02-21 2013-08-11 Eisai R&D Man Co Ltd 4- (3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives
AU2008215411B2 (en) 2007-02-16 2012-11-22 Eisai R & D Management Co., Ltd. Crystal, amorphous form and salt of methyl N-[3-(6,7-dimethoxy- 2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid
ATE538102T1 (de) 2007-08-17 2012-01-15 Eisai R&D Man Co Ltd Verfahren zur herstellung eines chinazolinderivats
AU2008290001B2 (en) 2007-08-17 2012-08-09 Eisai R & D Management Co., Ltd. Novel preparation for external use
EP2727594B1 (en) * 2011-06-28 2017-12-20 Mitsubishi Tanabe Pharma Corporation Naphtalene compounds to treat itch
SG10201907026RA (en) 2015-01-30 2019-09-27 Shanton Pharma Co Ltd Prevention or Treatment of Uratic or Gouty Diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930703319A (ko) * 1990-12-21 1993-11-29 데이빗 로버츠 키산틴 유도체
AU718752B2 (en) * 1996-03-26 2000-04-20 Altana Pharma Ag Novel phenanthridines substituted in the 6 position
WO1997043288A1 (en) * 1996-05-15 1997-11-20 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel imidazopyridines
ES2206909T3 (es) * 1997-03-07 2004-05-16 Altana Pharma Ag Derivados de tetrazol.
SI20110A (sl) * 1997-03-18 2000-06-30 Basf Aktiengesellschaft Metode in sestavki za moduliranje odzivnosti na kortikosteroide
US6384047B1 (en) * 1997-06-03 2002-05-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine

Also Published As

Publication number Publication date
KR20010031149A (ko) 2001-04-16
TR200001040T2 (tr) 2001-01-22
BR9814080A (pt) 2000-09-26
AU740875B2 (en) 2001-11-15
NO20001847D0 (no) 2000-04-10
IL135581A0 (en) 2001-05-20
NZ503551A (en) 2002-05-31
ZA989450B (en) 1999-04-19
EP1030666A4 (en) 2002-10-16
HUP0003792A3 (en) 2001-12-28
WO1999020280A1 (en) 1999-04-29
PL341062A1 (en) 2001-03-26
AR015966A1 (es) 2001-05-30
JP2001520196A (ja) 2001-10-30
AU1093899A (en) 1999-05-10
CN1306426A (zh) 2001-08-01
CA2306985A1 (en) 1999-04-29
CO4810374A1 (es) 1999-06-30
EP1030666A1 (en) 2000-08-30
CZ20001376A3 (cs) 2002-06-12
HUP0003792A2 (hu) 2001-10-28

Similar Documents

Publication Publication Date Title
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
IS5354A (is) Ný efnasambönd
ID24372A (id) SENYAWA-SENYAWA 4-AMINO-TIAZOL-2-IL SEBAGAI PENGHAMBAT-PENGHAMBAT CDKs
IS2027B (is) Ný spíróasabísýklísk heterósýklísk efnasambönd
ID24638A (id) Senyawa-senyawa anti aritmia bispidina
NO20015855L (no) Ny anvendelse av forbindelser som antibakterielle midler
NO20001847L (no) Ny anvendelse av forbindelser for anti-kløe-aktivitet
ID22878A (id) Komposisi aktif secara terapi
NO993298D0 (no) Ny fremgangsmÕte
ID29966A (id) Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi
ID24677A (id) Kombinasi senyawa aktif fungisidal
NO995796D0 (no) Ny fremgangsmåte
ID24270A (id) Penghilang sumbatan keratotik
FI963531A0 (fi) Kinoliini-3-karboksamidiyhdisteiden uusi käyttö
NO996438D0 (no) Ny kombinasjon av astmamedikamenter
FI963532A0 (fi) Kinoliini-3-karboksamidiyhdisteiden uusi käyttö
ID24694A (id) Pemakaian bentuk zat-zat sebagai katalis untuk pembuatan kaprolaktam
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ID24521A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ID19787A (id) Senyawa 25-hidroksi-16-ena-26,27-bishomo-kolekalsiferol
NO963762D0 (no) Ny anvendelse av kinolin-3-karboksamidforbindelser
NO963764D0 (no) Ny anvendelse av kinolin-3-karboksamidforbindelser
SE9704839D0 (sv) New compounds
SE9702535D0 (sv) New compounds
SE9704837D0 (sv) New compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application